[{"id":"0e136b5e-db43-41d6-9dbc-e487bfbe2822","acronym":"","url":"https://clinicaltrials.gov/study/NCT03825718","created_at":"2021-01-18T18:53:39.691Z","updated_at":"2025-02-25T15:08:17.270Z","phase":"Phase 1","brief_title":"A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL","source_id_and_acronym":"NCT03825718","lead_sponsor":"Hebei Yanda Ludaopei Hospital","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GC007F • S1904"],"overall_status":"Completed","enrollment":" Enrollment 29","initiation":"Initiation: 01/17/2019","start_date":" 01/17/2019","primary_txt":" Primary completion: 09/01/2020","primary_completion_date":" 09/01/2020","study_txt":" Completion: 12/01/2020","study_completion_date":" 12/01/2020","last_update_posted":"2022-04-28"}]